Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

ClinicalTrials.gov ID: NCT00647270

Public ClinicalTrials.gov record NCT00647270. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 26, 2026, 7:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Double-blind,Placebo-controlled Study Comparing 80 mg of Adalimumab With Placebo, and Demonstrating the Non-inferiority of Monthly 80 mg Adalimumab Dosing Compared With 40 mg Adalimumab Every Other Week Dosing

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To demonstrate the efficacy of 80 mg adalimumab monthly dosing compared with placebo and demonstrate the non-inferiority of monthly dosing of 80 mg adalimumab compared with dosing of 40 mg adalimumab every other week.

Study identification

NCT ID
NCT00647270
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2007
Primary completion
Mar 31, 2009
Completion
Mar 31, 2009
Last update posted
Apr 10, 2011

2007 – 2009

United States locations

U.S. sites
48
U.S. states
23
U.S. cities
47
Facility City State ZIP Site status
Not listed Huntsville Alabama 35801 —
Not listed Tuscaloosa Alabama 35406 —
Not listed Paradise Valley Arizona 85253 —
Not listed Hemet California 92543 —
Not listed Long Beach California 90806 —
Not listed Santa Monica California 90404 —
Not listed Torrance California 90505 —
Not listed Victorville California 92395 —
Not listed West Hills California 91307 —
Not listed Wheat Ridge Colorado 80033 —
Not listed Aventura Florida 33180 —
Not listed Orange Park Florida 32073 —
Not listed Palm Harbor Florida 34684 —
Not listed Sarasota Florida 34239 —
Not listed Tampa Florida 33614 —
Not listed Vero Beach Florida 32960 —
Not listed Atlanta Georgia 30342 —
Not listed Chicago Illinois 60612 —
Not listed Moline Illinois 61201 —
Not listed Springfield Illinois 62704 —
Not listed Wichita Kansas 67203 —
Not listed Lexington Kentucky 40515 —
Not listed Covington Louisiana 70433 —
Not listed Brighton Michigan 48116 —
Not listed Passaic New Jersey 07055 —
Not listed Smithtown New York 11787 —
Not listed The Bronx New York 10461 —
Not listed Ashville North Carolina 28801 —
Not listed Charlotte North Carolina 28209 —
Not listed Hickory North Carolina 28601 —
Not listed Monroe North Carolina 28112 —
Not listed Oklahoma City Oklahoma 73112 —
Not listed Bend Oregon 97701 —
Not listed Bethlehem Pennsylvania 18015 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Philadelphia Pennsylvania 19152 —
Not listed West Reading Pennsylvania 19611 —
Not listed Charleston South Carolina 29406 —
Not listed Greenville South Carolina 29601 —
Not listed Jackson Tennessee 38305 —
Not listed Nashville Tennessee 37205 —
Not listed Dallas Texas 75235 —
Not listed Houston Texas 77034 —
Not listed Houston Texas 77074 —
Not listed San Antonio Texas 78217 —
Not listed Ogden Utah 84405 —
Not listed Olympia Washington 98502 —
Not listed Glendale Wisconsin 53217 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00647270, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 10, 2011 · Synced Sep 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00647270 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →